Mucosal staining after using topical tacrolimus to treat erosive oral lichen planus.
Shen
John T
JT
Pedvis-Leftick
Anita
A
D000287:Administration, Topical; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D017676:Lichen Planus, Oral / Q000188:drug therapy*; D008875:Middle Aged; D009061:Mouth Mucosa / Q000473:pathology*; D010859:Pigmentation Disorders / Q000139:chemically induced* / Q000473:pathology; D016559:Tacrolimus / Q000009:adverse effects* / Q000627:therapeutic use
D007166:Immunosuppressive Agents; D016559:Tacrolimus